Table 3.

Efficacy and outcomes.

Patient No.	Hospitalization duration, days	Complications within 30 days	Requirement for reintervention	Control of bleeding within 30 days	Medication during follow-up	Survival (months) / cause of death
1	24	None	None	Yes	Clopidogrel 75 mg/day	10/disease progression
2	9	Distal embolization	Thrombus aspiration	Yes	Clopidogrel 75 mg/day	3/rebleeding
3	20	None	None	Yes	Clopidogrel 75 mg/day	13/alive
4	17	None	None	Yes	Clopidogrel 75 mg/day	10/disease progression
5	15	None	None	Yes	None	7/disease progression
6	21	None	None	Yes	Clopidogrel 75 mg/day	10/alive
7	23	None	None	Yes	Clopidogrel 75 mg/day	10/disease progression
8	25	Mild pelvic pain	None	Yes	None	7/sudden death
9	30	Rebleeding	Deployment of Viabahn	No	Clopidogrel 75 mg/day	13/alive
10	25	None	None	Yes	Clopidogrel 75 mg/day	7/disease progression
11	18	None	None	Yes	Clopidogrel 75 mg/day	10/disease progression
12	21	None	None	Yes	Clopidogrel 75 mg/day	13/alive